Analyses of the skin molecules in patients with Parkinson's disease and related diseases.
Not Applicable
- Conditions
- 1.Healthy adults 2.Parkinson's disease 3.Progressive supranuclear palsy 4.Multiple system atrophy 5.Normal pressure hydrocephalus
- Registration Number
- JPRN-UMIN000042501
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.Panelists who have the type I or II diabetes. 2.Panelists who have the malignant tumors. 3.Panelists who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris. 4.Panelists who have the infectious diseases, such as HIV, HCV, HIV, and syphilis. 5.Panelists who use the antibiotics within 2 weeks before participation in this study. 6.Panelists who use the prescription drugs having any effects to this study. 7.Panelists who use the prescription topical agents on the face 8.Panelists who is considered as inappropriate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The differences of skin molecules between healthy subjects, subjects with Parkinson's disease, and subjects with related diseases.
- Secondary Outcome Measures
Name Time Method The differences of blood components between healthy subjects, subjects with Parkinson's disease, and subjects with related diseases. The relationship of the molecules between skin and blood.